If the inhibitory effects of the CT domain of CCN2 prevail, absence of CCN2 may lead to a clefting phenotype similar to activating mutations of FGFR2c as seen in the numerous craniosynostosis syndromes. The gene discussed is CCN2; the disease is syndromic craniosynostosis.